Get started
Author

Nizar A. Al‐Shar’i

Observed names: Al-Shar'i, Nizar, Al-Shar’i, Nizar, Al-Shar’i, Nizar A, Al-Shar’i, Nizar A., N. A. Al-Shar I, Nizar A Al-shar’i, Nizar A. Al-Shar, Nizar A. Al-Shar'i, Nizar A. Al-Shar’I, Nizar A. Al-Shar’i, Nizar A. Al-shar'i, Nizar A. Al-shar’i, Nizar A. Al‐Shar'i, Nizar A. Al‑Shar’i, Nizar Al-Shar'i, Nizar Al-Shari, Nizar Al-Shar’i, Nizar Al-shar’i, Nizar Alshar'i, Nizar Alshari, Nizar Alshari’, Nizar Alshar’i, Nizar Al‑Shar'i
Institution: Qatar University
ORCID: 0000-0002-1599-5704
Observed ORCID: 0000-0002-1599-5704
OpenAlex ID: A5031313546
Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation
2021 · Hadeia Mashaqbeh, Rana Obaidat, et al. · Polymers · 136
PDF
Perspectives on RNA Vaccine Candidates for COVID-19
2021 · Pobitra Borah, Pran Kishore Deb, et al. · Frontiers in Molecular Biosciences · 67
PDF
In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis
2021 · Pran Kishore Deb, Nizar A. Al-Shar’i, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 64
PDF
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme
2021 · Katharigatta N. Venugopala, Sandeep Chandrashekharappa, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 58
PDF
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted
2021 · Pobitra Borah, Pran Kishore Deb, et al. · Frontiers in Molecular Biosciences · 54
PDF
Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies
2020 · Pobitra Borah, Pran K. Deb, et al. · Current Topics in Medicinal Chemistry · 51
Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1
2014 · Ammar Almaaytah, Shadi Tarazi, et al. · Pharmaceuticals · 48
PDF
Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19
2021 · Rajashri Bezbaruah, Pobitra Borah, et al. · Frontiers in Molecular Biosciences · 31
PDF
Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends
2019 · Nizar A. Al-Shar'i, Qosay A. Al-Balas · Current Pharmaceutical Design · 30
Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
2016 · Qosay Al-Balas, Mohammad Hassan, et al. · Drug Design Development and Therapy · 30
PDF
Recent Advances in Glyoxalase-I Inhibition
2018 · Qosay A. Al-Balas, Mohammad A. Hassan, et al. · Mini-Reviews in Medicinal Chemistry · 28
Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking
2019 · Nizar A. Al-Shar’i, Qosay A. Al-Balas, et al. · Journal of Computer-Aided Molecular Design · 24
Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides
2016 · Ammar Almaaytah, Ya'u Ajingi, et al. · Infection and Drug Resistance · 21
PDF
Enhancement of levodopa stability when complexed with β-cyclodextrin in transdermal patches
2016 · Rana Obaidat, Nizar Al-Shar'i, et al. · Pharmaceutical Development and Technology · 21
Explaining the autoinhibition of the SMYD enzyme family: A theoretical study
2016 · Nizar A. Al-Shar’i, Soraya M. Alnabulsi · Journal of Molecular Graphics and Modelling · 20
1,2,3-Triazolyl-tetrahydropyrimidine Conjugates as Potential Sterol Carrier Protein-2 Inhibitors: Larvicidal Activity against the Malaria Vector Anopheles arabiensis and In Silico Molecular Docking Study
2022 · Katharigatta N. Venugopala, Pottathil Shinu, et al. · Molecules · 19
PDF
Computational and experimental exploration of the structure–activity relationships of flavonoids as potent glyoxalase‐I inhibitors
2017 · Qosay A. Al‐Balas, Mohammad A. Hassan, et al. · Drug Development Research · 19
The Design and Functional Characterization of the Antimicrobial and Antibiofilm Activities of BMAP27-Melittin, a Rationally Designed Hybrid Peptide
2014 · Ammar Almaaytah, Shadi Tarazi, et al. · International Journal of Peptide Research and Therapeutics · 19
Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
2020 · Nizar A. Al-Shar’i, Qosay A. Al-Balas, et al. · Acta Pharmaceutica · 18
PDF
Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking
2019 · Nizar A. Al-Shar’i, Enas K. Al-Rousan, et al. · Medicinal Chemistry Research · 18
Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies
2024 · Katharigatta N. Venugopala, Sandeep Chandrashekharappa, et al. · International Journal of Biological Macromolecules · 17
PDF
Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents
2020 · Buthina A. Al-Oudat, Hana'a M. Jaradat, et al. · Bioorganic & Medicinal Chemistry · 17
Novel Thiazole Carboxylic Acid Derivatives Possessing a “Zinc Binding Feature” as Potential Human Glyoxalase-I Inhibitors
2017 · Qosay A. Al-Balasa, Mohammad A. Hassana, et al. · Letters in Drug Design & Discovery · 17
Synthesis, biological evaluation, and computational investigation of ethyl 2,4,6-trisubstituted-1,4-dihydropyrimidine-5-carboxylates as potential larvicidal agents against Anopheles arabiensis
2023 · Ramasamy Duraisamy, Nizar A. Al-Shar’i, et al. · Journal of Biomolecular Structure and Dynamics · 16
Tackling COVID-19: identification of potential main protease inhibitors via structural analysis, virtual screening, molecular docking and MM-PBSA calculations
2020 · Nizar A. Al-Shar’i · Journal of Biomolecular Structure and Dynamics · 16
Works count: 75
Citation count: 1,090
H-index: 18
I10-index: 35
Year
Topic
Type